Immobilization of Mesenchymal Stem Cells and Monocytes in Biocompatible Microcapsules to Cell Therapy

The aim of cell therapy is to replace, repair, or enhance the function of damaged tissues or organs. Several factors complicate the development of cellular therapies. Of primary importance is protection of the implanted cells from the hostapos;s immune system. Cells are encapsulated in selectively semipermeable and biocompatible membranes that block entry of immune mediators but allow outward diffusion of active molecules produced by the cells. The immobilization of mesenchymal stem cells and monocytes, in micrometric (30–60 μm) alginate‐barium microcapsules based on atomization processes, has been achieved successfully. This size is necessary to the administration of microcapsules via injection (Hamilton syringe with a needle size of 100 μm) and aerosol. Microencapsulated cells survive at least 2 weeks after preparation in vitro.

[1]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[2]  Gorka Orive,et al.  History, challenges and perspectives of cell microencapsulation. , 2004, Trends in biotechnology.

[3]  P. de Vos,et al.  Considerations for successful transplantation of encapsulated pancreatic islets , 2002, Diabetologia.

[4]  S. F. Chang,et al.  Chitosan microspheres: modification of polymeric chem-physical properties of spray-dried microspheres to control the release of antibiotic drug , 1999 .

[5]  Xiao-jun Ma,et al.  Swelling behaviour of alginate–chitosan microcapsules prepared by external gelation or internal gelation technology , 2004 .

[6]  P. Aebischer,et al.  Chitosan as a matrix for mammalian cell encapsulation. , 1994, Biomaterials.

[7]  M. Sefton,et al.  Microencapsulated human hepatoma (HepG2) cells: in vitro growth and protein release. , 1993, Journal of biomedical materials research.

[8]  E. D. Valle,et al.  Development of a new technology for the production of microcapsules based in atomization processes , 2006 .

[9]  P. Tresco,et al.  Technology of mammalian cell encapsulation. , 2000, Advanced drug delivery reviews.

[10]  S. Sugiura,et al.  Size control of calcium alginate beads containing living cells using micro-nozzle array. , 2005, Biomaterials.

[11]  B. Říhová Immunocompatibility and biocompatibility of cell delivery systems. , 2000, Advanced drug delivery reviews.

[12]  R. Robitaille,et al.  Studies on small (<350 microm) alginate-poly-L-lysine microcapsules. III. Biocompatibility Of smaller versus standard microcapsules. , 1999, Journal of biomedical materials research.

[13]  J. Hilborn,et al.  Alginate hydrogel microspheres and microcapsules prepared by spinning disk atomization. , 2000, Biotechnology and bioengineering.

[14]  Jiehong Liao,et al.  Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments. , 2005, Biotechnology and bioengineering.

[15]  P. Vos,et al.  Cell encapsulation: Promise and progress , 2003, Nature Medicine.

[16]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .

[17]  M. Sefton,et al.  Making microencapsulation work: conformal coating, immobilization gels and in vivo performance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Simon Benita,et al.  Microencapsulation : methods and industrial applications , 1996 .

[19]  K. Ando,et al.  Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation , 2003, Bone Marrow Transplantation.

[20]  D. Hunkeler,et al.  New Multicomponent Capsules for Immunoisolation , 1999, Annals of the New York Academy of Sciences.

[21]  P. Deluca,et al.  Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal Techniques , 2004, Pharmaceutical Research.

[22]  R. Schnettler,et al.  Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. , 1992, Transplantation proceedings.

[23]  D. Burgess,et al.  Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids , 1987 .

[24]  J. Kressler,et al.  Encapsulation of living cells with polymeric systems , 2004 .

[25]  D. Hunkeler,et al.  Improving cell encapsulation through size control , 2002, Journal of biomaterials science. Polymer edition.

[26]  B. Kulseng,et al.  Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. , 2001, Cell transplantation.

[27]  Diane J. Burgess,et al.  Manufacture of gelatin/gelatin coacervate microcapsules , 1985 .

[28]  J. Brash,et al.  Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. , 1998, Journal of biomedical materials research.

[29]  D. Hunkeler,et al.  Rationalizing the design of polymeric biomaterials. , 1999, Trends in biotechnology.

[30]  T. Chandy,et al.  Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. , 1999, Artificial organs.

[31]  J. Benoit,et al.  Characterization of drug-loaded poly(d,l-lactide) microspheres. , 1984, Journal of pharmaceutical sciences.

[32]  E. Shaulian,et al.  Induction of Mdm2 and enhancement of cell survival by bFGF , 1997, Oncogene.

[33]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[34]  G. Camussi,et al.  Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.

[35]  G. Skjåk-Bræk,et al.  Microcapsules of alginate-chitosan. II. A study of capsule stability and permeability. , 1999, Biomaterials.

[36]  A. Urbanska,et al.  Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules. , 2005, Molecular pharmaceutics.

[37]  C. Heinzen,et al.  Characterization of an encapsulation device for the production of monodisperse alginate beads for cell immobilization. , 2000, Biotechnology and bioengineering.

[38]  E. D. Valle,et al.  Modelling prediction of the microcapsule size of polyelectrolyte complexes produced by atomization , 2006 .

[39]  J. Pedraz,et al.  Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation. , 2003, International journal of pharmaceutics.

[40]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[41]  Sinjan De,et al.  Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[42]  G. Skjåk-Bræk,et al.  The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan , 1998 .